Live Quote · NASDAQDERMHealthcare· Drug Manufacturers - Specialty & Generic

Journey Medical Corporation

$7.09 0.71%(+$0.05)
TickerSpark Score
61/100
Mixed
55
Valuation
40
Profitability
90
Growth
72
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DERM research report →

52-Week Range53% of range
Low
$4.31
Current
$7.09
High
$9.55
Company Overviewjourneymedicalcorp.com

About the company

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc. ), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution.

CEO
Claude Maraoui
IPO
2021
Employees
41
HQ
Scottsdale, AZ, US

Price Chart

+0.71% · this period
$9.26$6.82$4.39Jul 02Dec 31Jul 02
Valuation
Market Cap
$195.13M
P/E
-18.86
P/S
3.02
P/B
6.28
EV/EBITDA
-134.10
Div Yield
0.00%
Profitability
Gross Margin
60.41%
Op Margin
-9.80%
Net Margin
-14.82%
ROE
-35.57%
ROIC
-11.26%
Growth & Income
Revenue
$61.86M · 10.20%
Net Income
$-11,431,000 · 22.09%
EPS
$-0.47 · 34.72%
Op Income
$-8,172,000
FCF YoY
-36.31%
Performance & Tape
52W High
$9.55
52W Low
$4.31
50D MA
$5.93
200D MA
$7.11
Beta
1.07
Avg Volume
272.86K

Get TickerSpark's AI analysis on DERM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 1, 26Toledano Miranda Jayneother50,000
Jul 1, 26Smith Justin Adamother50,000
Jul 1, 26Herskowitz Neilother50,000
Jun 25, 26Toledano Miranda Jayneother10,000
Jun 25, 26Smith Justin Adamother10,000
Jun 25, 26Herskowitz Neilother10,000
Jun 25, 26Pearce Michael Cooperother10,000
Jun 25, 26ROSENWALD LINDSAY A MDother10,000
Apr 22, 26Alloush Ramseyother46,863
Apr 22, 26Alloush Ramseyother62,795
Coverage · DERM

Our DERM coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on DERM yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate DERM report →
Internal Compare

Similar companies

Peers in the same neighborhood.